🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
17.58
-0.96 (-5.18%)
At close: Nov 20, 2026, 4:00 PM EST
18.00
+0.42 (2.39%)
After-hours: Nov 20, 2026, 7:30 PM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Molecular Profiling Services Revenue
1.01B766.72M349.12M
Pharma Research and Development Services Revenue
40.24M45.31M63.15M
Revenue (Total)
1.05B812.03M412.26M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States Revenue
1.04B801.39M401.84M
International Revenue
9.75M10.64M10.42M
Revenue (Total)
1.05B812.03M412.26M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Molecular Intelligence (MI) Profile - Clinical Case Volume
-170.30K146.60K
Caris Assure - Clinical Case Volume
-29.00K16.30K
Total Clinical Case Volume
226.20K199.30K162.90K
Molecular Intelligence (MI) Profile - Clinical Average Selling Price (ASP)
-4.03K2.20K
Caris Assure - Clinical Average Selling Price (ASP)
-2.80K1.65K